Association of Codon 108/158 Catechol-O-Methyltransferase Gene Polymorphism with the Psychiatric Manifestations of Velo-Cardio-Facial Syndrome

American Journal of Medical Genetics - Seminars in Medical Genetics

Volumn 67, Issue 5, 1996, Pages 468-472

  Lachman, Herbert M ^a,b   Morrow, Bernice ^a   Shprintzen, Robert ^a   Veit, Sabine ^a   Parsia, Sam S ^b   Faedda, Gianni ^a   Goldberg, Rosalie ^a   Kucherlapati, Raju ^a   Papolos, Demitri F ^a  

^a Department of Medicine ^*  (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Bipolar disorder; Catecholamine O methyltransferase; Rapid cycling; Schizophrenia; Velocardio facial syndrome

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CHROMOSOME 22Q; CLINICAL ARTICLE; CODON; CONGENITAL MALFORMATION; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; HOMOZYGOSITY; HUMAN; MALE; MANIC DEPRESSIVE PSYCHOSIS; MINIMAL BRAIN DYSFUNCTION; PRIORITY JOURNAL; SCHIZOPHRENIA; SCHOOL CHILD;

ABNORMALITIES, MULTIPLE; ADOLESCENT; ADULT; CATECHOL O-METHYLTRANSFERASE; CHILD; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 22; CLEFT PALATE; CODON; FACE; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; LEARNING DISORDERS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SYNDROME;

EID: 0029745410     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19960920)67:5<468::AID-AJMG5>3.0.CO;2-G     Document Type: Article

References (33)

1. Aksoy S, Kiener J, Weinshilboum RM (1993): Catechol-O-methyl-transferase pharmacogenetics: Photoaffinity labelling and Western blot analysis of human liver samples. Pharmacogenetics 3:116-122.
2. Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosooff A, Ackerman BA (1995): Antidepressant-induced mania and cycle acceleration: A controversy revisited. Am J Psychiatry 152: 1130-1138.
3. Axelrod J, Tomchick R (1958): Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem 233:702-705.
4. Bertocci B, Miggiano V, Da Prada M, Dembric Z, Lahm H-W, Malherbe P (1991): Human catechol-O-methyltransferase: Cloning and expression of the membrance associated form. Proc Natl Acad Sci USA 88:1416-1420.
5. Boudikova B, Szumlanski C, Maidak B, Weinshilboum RM (1990): Human liver catecholamine-O-methylatransferase pharmacogenetics. Clin Pharmacol Ther 48:381-389.
6. Chow EWC, Bassett AS, Weksberg R (1994): Velo-cardio-facial syndrome and psychotic disorders: Implications for psychiatric genetics. Am J Med Genet 54:107-112.
7. Cook EH, Stein MA, Krasowski MD, Cox NJ, Olken DM, Kieffer JE, Leventhal BL (1995): Association of attention deficit disorder and the dopamine transporter gene. Am J Hum Genet 56:993-998.
8. Diehl DJ, Gershon (1992): The role of dopamine in mood disorders. Comp Psychiatry 33:115-120.
9. Dunner DL, Levitt M, Kumbaraci T, Fieve RR (1977): Erythrocyte catechol-O-methyltransferase activity in primary affective disorder. Biol Psychiatry 12:237-244.
10. Goldberg RB, Motzkin R, Marion R, Scambler PJ, Shprintzen RJ (1993): Velo-cardio-facial-syndrome: A review of 120 patients. Am J Med Genet 45:313-319.
11. Grossman MH, Emanuel BS, Budarf ML (1992): Chromosomal mapping of the human catechol-O-methyl transferase gene to 22q11.1-q11.2. Genomics 12:822-825.
12. Halford S, Wadey R, Roberts C, et al. (1993): Isolation of a putative transcription regulator from the region of 22q11 deleted in DiGeorge syndrome, Shprintzen sydrome and familial congenital heart disease. Hum Mol Genet 2:2099-2107.
13. Herjanic B, Campbell W (1979): Differentiating psychiatrically disturbed children on the basis of structured interview. J Abnorm Child Psychol 5:127-143.
14. Herjanic B, Reich W (1982): Development of a structured psychiatric interview for children: Agreement between child and parent on individual symptoms. J Abnorm Child Psychol 10:307-324.
15. Kahn RS, Davis KL (1995): New developments in dopamine and schizophrenia. In Bloom F, Kupfer D (eds): "Psychopharmacology: The Fourth Generation of Progress." New York: Raven Press Ltd, pp 1193-1203.
16. Karege F, Bovier J-M, Tissot R (1987): The decrease of erythorcyte catechol-O-methyltransferase activity in depressed patients and its diagnostic significance. Acta Psychiatr Scand 76:303-308.
17. Lachman H, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM (1996): Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics, (in press).
18. Lindsay EA, Goldberg R, Jurecic V, Morrow B, Carlson C, Kucherlapati R, Shprintzen RJ, Baldini A (1995); Velo-cardio-facial syndrome: Frequency and extent of 22q11 deletions. Am J Med Genet 57: 514-522.
19. Lotta T, Vidgren J, Tilgmann C, Umanen I, Melen K, Julkunen I, Taskinen J (1995): Kinetics of human soluble and membrane bound catechol-O-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34:4202-4210.
20. Lundstrom K, Salminen M, Jalanko A, Savolainen R, Ulmanen I (1991): Cloning and characterization of human placental catechol-0-methyltransferase cDNA. DNA Cell Biol 10:181-189.
21. Morrow B, Goldberg R, Carlson C, Gupta RD, Sirotkin H, Collins J, Dunham I, O'Donnell H, Scrambler P, Shprintzen R, Kucherlapati R(1995): Molecular definition of the 22q11 deletions in velo-cardiofacial syndrome. Am J Hum Genet 56:1391-1403.
22. Papolos DF, Faedda G, Veit S, Shprintzen R, Goldberg R, Morrow B, Kucherlapati R (1995): Bipolar affective disorder in patients diagnosed with velo-cardio-facial-syndrome. Soc Neurosci Abstr p259.
23. Philippu C, Hoo JJ, Milech U, Argarwall DP, Schrappe O, Goedde HW (1981): Catechol-O-methyltransferase activity of erythorcytes in patients with endogenous psychosis. Psychiatry Res 4:139-146.
24. Pulver AE, Nestadt G, Goldberg R, Shprintzen RJ, Lamacz M, Wolyniec PS, Morrow B, Karayiorgou M, Antonarakis SE, Housman D, Kucherlapati R (1994): Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives J Nerv Ment Dis 182:476-478.
25. Puzynski S, Bidzinsky A, Mrozek S, Zaluska M (1983): Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illness. II. Erythrocyte catechol-O-methyltransferase activity in endogenous depression. Acta Psychiatr Scand 67:96-100.
26. Reich W, Cottler L, McCallum K, Corwin D, Van Eerdewegh M (1995): Computerized interviews as a method of assessing psychopathology in children. Comprehensive Psychiatry 36(1):40-45.
27. Scambler P, Kelly D, Lindsay E, Williamson R, Goldberg R, Shprintzen R, Wilson DI (1992): Velo cardio facial syndrome associated with chromosome 22q11 deletions encompassing the DiGeorge Locus. Lancet 339:1138-1139.
28. Scanlon PD, Raymond FA, Weinshilboum RA (1979): Catechol-O-methyl transferase: Thermolabile enzyme in erythrocytes of subjects homozygous for the allele for low activity. Science 203: 63-65.
29. Shprintzen RJ, Goldberg RB, Lewin ML, Sidoti EJ, Berkman, MD, Argamaso RV, Young DA (1978): A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: Velo-cardio-facial syndrome. Cleft Palate J 15:56-62.
30. Shprintzen RJ, Goldberg RB, Golding-Kushner KJ, Marion RW (1992): Late-onset psychosis in the velo-cardio-facial syndrome. Am J Med Genet 42:141-142.
31. Spielman RS, Weinshilboum RM (1981): Genetics of red cell COMT activity: Analysis of thermal stability and family data. Am J Med Genet 10:279-290.
32. Tenhunen J, Salminen M, Lundstrom K, Kiviluoto T, Savolainen R, Ulmanen I (1994): Genomic organization of the human catechol-O-methyltransferase gene and its expression from two distinct promoters. Eur J Biochem 223:1049-1054.
33. Weinshilboum RM, Raymond FA (1977): Inheritance of low erythrocyte catechol-O-methyltransferase activity in man. Am J Hum Genet 29:125-135.